Osiris Therapeutics, Inc. (OSIR) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Diluted earnings per share (in dollars per share): -0.02
Today's EPS Names:
AFIB, USDP, BTTX, More
Financial Fact:
Diluted earnings per share (in dollars per share): -0.02
Today's EPS Names:
AFIB, USDP, BTTX, More
Join SI Premium – FREE
Osiris Therapeutics, Inc. (NASDAQ: OSIR) reported Q4 EPS of $0.15, $0.04 better than the analyst estimate of $0.11. Revenue for the quarter came in at $10.28 million versus the consensus estimate of $10.68 million.
For earnings history and earnings-related data on Osiris Therapeutics, Inc. (OSIR) click here.
For earnings history and earnings-related data on Osiris Therapeutics, Inc. (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- reAlpha Tech Corp. (AIRE) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
